Search Results - "Barnett, Chad M."

Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer by JIRALERSPONG, Sao, PALLA, Shana L, GIORDANO, Sharon H, MERIC-BERNSTAM, Funda, LIEDTKE, Cornelia, BARNETT, Chad M, HSU, Limin, HUNG, Mien-Chie, HORTOBAGYI, Gabriel N, GONZALEZ-ANGULO, Ana M

“…Population studies have suggested that metformin use in diabetic patients decreases cancer incidence and mortality. Metformin inhibits the growth of cancer…”
Get full text

Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer: Past, Present, and Future by DiPippo, Adam J., Patel, Neelam K., Barnett, Chad M.

“…Treatment of metastatic breast cancer (MBC) that is resistant to endocrine therapy presents a significant clinical challenge. The well‐known role of cell cycle…”
Get full text

Ado-trastuzumab emtansine (T-DM1): a novel antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer by Baron, Jessica M, Boster, Bonnie L, Barnett, Chad M

“…Human epidermal growth factor receptor-2 (HER2)-positive breast cancer is an aggressive form of breast cancer associated with poorer prognosis and shortened…”
Get full text

Everolimus: Targeted Therapy on the Horizon for the Treatment of Breast Cancer by Barnett, Chad M.

“…The mammalian target of rapamycin (mTOR) is a signaling kinase of the phosphatidylinositol 3‐kinase/protein kinase B (also known as Akt) signaling pathway that…”
Get full text

Incidence, Risk Factors, and Management of Infusion‐Related Reactions in Breast Cancer Patients Receiving Trastuzumab by Thompson, Lisa M., Eckmann, Karen, Boster, Bonnie L., Hess, Kenneth R., Michaud, Laura B., Esteva, Francisco J., Hortobágyi, Gabriel N., Barnett, Chad M.

“…Learning Objectives Identify risk factors associated with trastuzumab‐associated infusion‐related reactions. Describe the impact of premedications on the…”
Get full text

Evaluation of pharmacist-provided medication therapy management services in an oncology ambulatory setting by Watkins, Jack L., PharmD, BCOP, Landgraf, Andrea, PharmD, BCOP, Barnett, Chad M., PharmD, BCOP, Michaud, Laura, PharmD, BCOP, FASHP

“…Abstract Objectives To determine the effect of formal medication therapy management (MTM) services on pharmacist workload, as well as to describe the…”
Get full text

Timely Genetic Testing and Therapy Management in Patients With gBRCA-Mutated Metastatic Breast Cancer Receiving Talazoparib by Martinez, DNP, APRN, FNP-BC, AOCNP, CBCN, CPHQ, NEA-BC, Ashley, Jones, MSN, ACNP-BC, Tiffany, C. Ryan, PhD, RN, Joanne, M. Barnett, PharmD, BCOP, Chad, L. Soussou, PharmD, MBA, Elpitha, Donahue, MPH, NP, AOCNP, Sarah

“…Talazoparib is a poly(ADP-ribose) polymerase (PARP) inhibitor that has demonstrated strong efficacy with manageable side effects for patients with germline…”
Get full text

Outcomes of children exposed in utero to chemotherapy for breast cancer by Murthy, Rashmi K, Theriault, Richard L, Barnett, Chad M, Hodge, Silvia, Ramirez, Mildred M, Milbourne, Andrea, Rimes, Sue A, Hortobagyi, Gabriel N, Valero, Vicente, Litton, Jennifer K

“…The incidence of breast cancer diagnosed during pregnancy is expected to increase as more women delay childbearing in the United States. Treatment of cancer in…”
Get full text

Pertuzumab: A New Targeted Therapy for HER2-Positive Metastatic Breast Cancer by Malenfant, Stephanie J., Eckmann, Karen R., Barnett, Chad M.

“…Trastuzumab, a humanized monoclonal antibody, has become an important targeted therapy for patients with all stages of human epidermal growth factor receptor‐2…”
Get full text

Survival Data of Patients with Anthracycline- or Taxane Pretreated or Resistant Metastatic Breast Cancer by Barnett, Chad M.

“…Metastatic breast cancer is considered incurable. Despite effective response rates achieved with anthracycline or taxane anticancer drugs, cancers in…”
Get full text

Outcomes of children exposed in uteroto chemotherapy for breast cancer by Murthy, Rashmi K, Theriault, Richard L, Barnett, Chad M, Hodge, Silvia, Ramirez, Mildred M, Milbourne, Andrea, Rimes, Sue A, Hortobagyi, Gabriel N, Valero, Vicente, Litton, Jennifer K

“…Introduction The incidence of breast cancer diagnosed during pregnancy is expected to increase as more women delay childbearing in the United States. Treatment…”
Get full text

Evaluation of Pharmacist Provided Medication Therapy Management Services in an Oncology Ambulatory Setting at a Comprehensive Cancer Center: Medication Therapy Management in the Oncology Ambulatory Setting by Watkins, Jack L., Landgraf, Andrea, Barnett, Chad M., Michaud, Laura

Get full text

Evaluation of Aprepitant for Treatment of Acute and Delayed Chemotherapy-Induced Nausea and Vomiting in Patients Undergoing Autologous Stem Cell Transplantation by Barnett, Chad M., Oholendt, Michael S., Popat, Uday, Carrum, George, Heslop, Helen E.

“…Autologous stem cell transplant (ASCT) requires therapy with very highly emetogenic chemotherapy regimens. Nausea and emesis are a major issue for patients…”
Get full text